Sanofi wins approval for second MS treatment
PARIS, Sept 17
PARIS, Sept 17 (Reuters) - French drugmaker Sanofi said it won approval from European authorities for a second multiple sclerosis treatment, paving the way to start selling both drugs in the region soon.
The marketing authorisation for Lemtrada from the European Commission follows a similar green light for Aubagio on Aug. 30, Sanofi said in a statement on Tuesday.
"The company intends to begin launching both products in the EU soon," Sanofi said. (Reporting by James Regan; Editing by David Cowell)
- Cortege departs to take Mandela's body to lie in state |
- U.S. Mega Millions lottery up to $344 million, fourth biggest in its history
- Uruguay becomes first country to legalize marijuana trade
- UPDATE 1-U.S. Mega Millions lottery up to $344 million, fourth biggest in its history
- Ukrainian riot police clash with protesters in Kiev square